Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- APL-101Phase 21 trial
Apollomics Inc. · Solid Tumors, Advanced Cancer, Renal Cancer
- APL-3007Phase 21 trial
Apellis Pharmaceuticals, Inc. · Geographic Atrophy Secondary to Age-related Macular Degeneration
- APL-9796Phase 21 trial
Apollo Therapeutics Ltd · Pulmonary Arterial Hypertension
- ApomivirFE-L-APO, drug substancePhase 21 trial
Far East Bio-Tec Co., Ltd · Influenza
- AR-17043Phase 21 trial
Alcon Research · Open Angle Glaucoma, Ocular Hypertension
- ARCT-032Phase 21 trial
Arcturus Therapeutics, Inc. · Cystic Fibrosis, CFTR Gene Mutation
- ARCT-2304Phase 21 trial
Arcturus Therapeutics, Inc. · Influenza, Human
- ARCT-810Phase 21 trial
Arcturus Therapeutics, Inc. · OTC Deficiency, Ornithine Transcarbamylase Deficiency, OTCD
- ARD-501Phase 21 trial
Aardvark Therapeutics, Inc. · Autism Spectrum Disorder
- ARD001Phase 21 trial
Arditus Pte Ltd · Hemophilia A, Healthy Adult Participants
- ARD103Phase 21 trial
ARCE Therapeutics, Inc. · Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, MDS (Myelodysplastic Syndrome)
- ARGX-119Phase 21 trial
argenx · Spinal Muscular Atrophy (SMA)
- ARGX-121Phase 21 trial
argenx · Immunoglobulin A Nephropathy (IgAN)
- AritinerceptPhase 21 trial
Aurinia Pharmaceuticals Inc. · Myasthenia Gravis, Generalized
- ART0380Phase 21 trial
Artios Pharma Ltd · Advanced Cancer, Metastatic Cancer, Ovarian Cancer
- ART5803Phase 21 trial
Arialys Australia Pty Ltd · Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE), Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease, Autoimmune Encephalitis
- ART6043Phase 21 trial
Artios Pharma Ltd · Advanced Solid Tumor, Metastatic Solid Tumor
- ARV-6723Phase 21 trial
Arvinas Inc. · Advanced Solid Tumor
- ARV-806Phase 21 trial
Arvinas Inc. · KRAS G12D Mutation, Advanced Solid Cancer
- ARX788Phase 21 trial
Ambrx, Inc. · HER2 Positive Metastatic Breast Cancer
- AS1986NSPhase 21 trial
Antelope Surgical Solutions, Inc · Prostate Cancer, Prostate Cancer (Adenocarcinoma), Fluorescence Imaging
- ASC618Phase 21 trial
ASC Therapeutics · Hemophilia A
- ASCA101Phase 21 trial
MetaFines · Cachexia; Cancer
- ASK0912Phase 21 trial
Jiangsu Aosaikang Pharmaceutical Co., Ltd. · Ventilator-associated Bacterial Pneumonia (VABP), Hospital-acquired Bacterial Pneumonia (HABP)
- AskBio009BAX 335Phase 21 trial
Takeda · Hemophilia B
- ASKG712AM712, VIS-101Phase 21 trial
Visara, Inc. · Neovascular Age-related Macular Degeneration
- ASKG915Phase 21 trial
AskGene Pharma, Inc. · Advanced Solid Tumors
- ASN-3186Phase 21 trial
Jiangsu Yahong Meditech Co., Ltd aka Asieris · Advanced Solid Tumors
- ASP2246Phase 21 trial
Astellas · Chronic Ischemic Stroke
- ASP2767Phase 21 trial
Astellas · Glaucoma
- ASP2957MyoAAV3.8 engineered capsid - myosin heavy chain kinase 7 - human myotubularin, MyoAAV3.8-MHCK7-hMTM1Phase 21 trial
Astellas · X-linked Myotubular Myopathy
- ASP2998Phase 21 trial
Astellas · Locally Advanced or Metastatic Malignant Solid Tumors
- ASP388BPhase 21 trial
Astellas · Locally Advanced or Metastatic Solid Tumors
- ASP5541PRL-02Phase 21 trial
Astellas · Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
- AST-201Phase 21 trial
Aston Sci. Inc. · Advanced Ovarian Cancer
- AST-301pNGVL3-hICDPhase 21 trial
Aston Sci. Inc. · Gastric Cancer
- ASTX660Phase 21 trial
Taiho Oncology, Inc. · Solid Tumors, Lymphoma
- AT-004Phase 21 trial
Arctic Therapeutics · Acne Vulgaris on the Face
- AT02Phase 21 trial
Attralus, Inc. · Amyloidosis; Systemic
- AT101Anti-CD19 Chimeric Antigen Receptor T cellPhase 21 trial
AbClon · B-cell Non Hodgkin Lymphoma
- AT673Phase 21 trial
Antag Therapeutics · Adults With Overweight/Obesity and Type 2 Diabetes
- atamparibPhase 21 trial
Nerviano Medical Sciences (Shanghai) Ltd. · NSCLC Adenocarcinoma, Solid Tumor
- ATB1651-102Phase 21 trial
AmtixBio Co., Ltd. · Onychomycosis
- ATH-063Phase 21 trial
Athos Therapeutics Inc · Ulcerative Colitis, Inflammatory Bowel Diseases, Autoimmune Diseases
- ATI-045Phase 21 trial
Aclaris Therapeutics, Inc. · Atopic Dermatitis, Atopic, Dermatitis
- atilizumabPhase 21 trial
Abbisko Therapeutics Co, Ltd · Hepatocellular Carcinoma
- ATR 1072Phase 21 trial
Atrium Therapeutics · Cardiac Glycogenosis, Cardiomyopathy, Hypertrophic
- ATR04-484ATR-04Phase 21 trial
Azitra Inc. · EGFR Inhibitor-associated Rash
- ATRN-119Phase 21 trial
Aprea Therapeutics · Advanced Solid Tumor
- ATSN-101Phase 21 trial
Atsena Therapeutics Inc. · Leber Congenital Amaurosis, LCA, LCA1
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.